MET and gastric cancer: Consistent with this, Yashiro et al. reported a synergistic anti-proliferative and pro-apoptotic effect of the MET inhibitor SU11274 with SN38 in chemoresistant CSCs derived from gastric cancer cell lines (side population-enriched cancer stem cells (SP-CSCs)) [67].